
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4688825
[patent_doc_number] => 20080033006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => '1,2,4-Triazolo[\n1,5-A]\nPyridines as Gastric Acid Secretion Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/586613
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9177
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20080033006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586613 | 1,2,4-Triazolo[n1,5-A]nPyridines as Gastric Acid Secretion Inhibitors | Jan 24, 2005 | Abandoned |
Array
(
[id] => 817153
[patent_doc_number] => 07410961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => '2,6-disubstituted piperiddines as modulators'
[patent_app_type] => utility
[patent_app_number] => 10/586765
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16498
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586765 | 2,6-disubstituted piperiddines as modulators | Jan 13, 2005 | Issued |
Array
(
[id] => 7051400
[patent_doc_number] => 20050187287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Conformationally constrained paclitaxel analogs and their use as anticancer and anti-alzheimers agents'
[patent_app_type] => utility
[patent_app_number] => 11/035037
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13670
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035037 | Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents | Jan 13, 2005 | Issued |
Array
(
[id] => 6912999
[patent_doc_number] => 20050176757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders'
[patent_app_type] => utility
[patent_app_number] => 11/031623
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18144
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176757.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031623 | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders | Jan 6, 2005 | Issued |
Array
(
[id] => 352806
[patent_doc_number] => 07491828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Liquid phase process for the synthesis of annulated pyridines over molecular sieve catalysts'
[patent_app_type] => utility
[patent_app_number] => 11/027484
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2635
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491828.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027484
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027484 | Liquid phase process for the synthesis of annulated pyridines over molecular sieve catalysts | Dec 29, 2004 | Issued |
Array
(
[id] => 5225642
[patent_doc_number] => 20070254909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same'
[patent_app_type] => utility
[patent_app_number] => 10/585029
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30203
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585029 | Pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same | Dec 29, 2004 | Issued |
Array
(
[id] => 439834
[patent_doc_number] => 07259268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Method for purification of paclitaxel from paclitaxel-containing materials'
[patent_app_type] => utility
[patent_app_number] => 11/028487
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3672
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259268.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028487 | Method for purification of paclitaxel from paclitaxel-containing materials | Dec 29, 2004 | Issued |
Array
(
[id] => 4985142
[patent_doc_number] => 20070151479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Acidic monoazo dyestuffs'
[patent_app_type] => utility
[patent_app_number] => 10/585231
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9229
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20070151479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585231 | Acidic monoazo dyestuffs | Dec 22, 2004 | Abandoned |
Array
(
[id] => 5247914
[patent_doc_number] => 20070244148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment'
[patent_app_type] => utility
[patent_app_number] => 10/583814
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32030
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583814 | Imidazo 4,5-c pyridine compounds and methods of antiviral treatment | Dec 20, 2004 | Issued |
Array
(
[id] => 5029011
[patent_doc_number] => 20070270458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Nicotinic Acetylcholine Receptor Ligands'
[patent_app_type] => utility
[patent_app_number] => 10/583582
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7021
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583582
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583582 | Nicotinic Acetylcholine Receptor Ligands | Dec 19, 2004 | Abandoned |
Array
(
[id] => 5290998
[patent_doc_number] => 20090023728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => '1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/596546
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50220
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596546 | 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof | Dec 19, 2004 | Abandoned |
Array
(
[id] => 4971992
[patent_doc_number] => 20070111995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/596561
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78567
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596561 | Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors | Dec 16, 2004 | Abandoned |
Array
(
[id] => 574874
[patent_doc_number] => 07459463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-02
[patent_title] => 'Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt'
[patent_app_type] => utility
[patent_app_number] => 10/582838
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10964
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582838
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582838 | Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt | Dec 15, 2004 | Issued |
Array
(
[id] => 4983459
[patent_doc_number] => 20070088018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Cb1 antagonist compounds'
[patent_app_type] => utility
[patent_app_number] => 10/596495
[patent_app_country] => US
[patent_app_date] => 2004-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40346
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596495
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596495 | CB1 antagonist compounds | Dec 12, 2004 | Issued |
Array
(
[id] => 4652213
[patent_doc_number] => 20080039469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Muscarinic Agents as Therapeutic Compounds'
[patent_app_type] => utility
[patent_app_number] => 10/581833
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6681
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581833 | Muscarinic agents as therapeutic compounds | Dec 5, 2004 | Issued |
Array
(
[id] => 6959610
[patent_doc_number] => 20050215584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/004365
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46395
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004365 | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease | Dec 2, 2004 | Abandoned |
Array
(
[id] => 849225
[patent_doc_number] => 07381743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'Macrocycles for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/580992
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8444
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580992 | Macrocycles for the treatment of cancer | Nov 25, 2004 | Issued |
Array
(
[id] => 7688808
[patent_doc_number] => 20070105890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Novel condensed imidazole derivative'
[patent_app_type] => utility
[patent_app_number] => 10/580321
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73100
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580321 | Novel condensed imidazole derivative | Nov 23, 2004 | Abandoned |
Array
(
[id] => 7688802
[patent_doc_number] => 20070105896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => '4-Substituted imidazoles'
[patent_app_type] => utility
[patent_app_number] => 10/579609
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6180
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579609
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579609 | 4-substituted imidazoles | Nov 14, 2004 | Issued |
Array
(
[id] => 303763
[patent_doc_number] => 07534902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Fluorescence assays with improved sensitivity'
[patent_app_type] => utility
[patent_app_number] => 10/988979
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10336
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988979
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988979 | Fluorescence assays with improved sensitivity | Nov 14, 2004 | Issued |